Posts Tagged

Artificial Intelligence

A group including NatWest, Bank of America, ING, Capital One, Commonwealth Bank of Australia and ASB has warned that AI shopping agents can create fraud, privacy and recourse risks. The banks’ proposed principles include disclosing when an agent is acting, explaining material decisions, protecting data and preserving consumer choice and interoperability. These are industry proposals, not a binding global standard. From search assistance to delegated action The issue is

According to a publication issued in September 2026, Marsh Re sees greater buyer choice and more bespoke cyber reinsurance structures. It expects European premium growth close to 10% in 2026 despite double-digit rate reductions. These trends can coexist as insured exposure, limits and take-up change; the figures remain a market outlook, not a guarantee. AI adds urgency because automated tools can shorten the period between discovery of a vulnerability

In September 2026, Reuters reported that an International Monetary Fund (IMF) paper presented to European finance ministers estimated that artificial intelligence could raise European productivity by about 1% over five years. The estimate is meaningful but modest enough to challenge unrealistic expectations. In a speech accompanying the analysis, IMF Managing Director Kristalina Georgieva argued that productivity gains depend on organisations redesigning products, processes and workflows rather than simply adding

In March 2026, Vitality, a member of Discovery Limited of South Africa, announced that its US acquisition of Ramp Health would combine an AI-enabled health platform with onsite clinical, coaching and workplace-safety services for employers. The transaction brings together two forms of intervention that are often purchased separately. Vitality contributes behavioural science, incentives, data analytics and personalised health-risk insights. Ramp Health adds clinicians, coaches and safety professionals who can

In September 2026, the New Jersey Legislature’s published text of Senate Bill 1029 placed human medical accountability at the centre of a proposed framework for health claims and automated utilisation management. The bill would require every claim submitted to a payer to be reviewed by at least one physician or medical director employed by, or contracted with, the payer. It would also require annual public reporting on approvals, denials,

In September 2026, The Wall Street Journal reported that Vitruvian Partners was leading a 600 million dollar investment in Angle Health at a 2.7 billion dollar valuation. The transaction is expected to include 200 million dollars of new equity and a 400 million dollar secondary component providing liquidity to existing shareholders. Other participants named in the report include Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital and Y

In September 2026, AXA’s official presentation of its 2027–2029 strategic plan, Growing Forward, made artificial intelligence one of the most explicit value-creation levers in the group’s next phase of development. At first sight, another major insurer intends to use more AI. In fact, this goes further. AXA has attached a recurring pre-tax value target of €500 million to €700 million by 2029 to its AI programme, while aiming for

McKinsey’s research division McKinsey Global Institute, in April 2018 published a discussion paper on the impact of artificial intelligence (AI). Applications and relevance of AI are broken down by industry and by corporate function, for an in-depth and nuanced analysis. “Notes From the AI Frontier: Insights From Hundreds of Use Cases” in particular focuses on the relevance of so-called “deep learning” techniques. Deep learning refers to techniques known as